Is the Bear coming out of hibernation in stock markets?
Whenever the market tanks 20% from its peak, it is technically termed as Bear market. So far, the Indian market has tanked 15% from its peak in November 2021.
share market india
May 2022
March 2022
February 2022
This Maharatna company rallied 32% in four sessions; here’s why
The stock of this state-owned company has risen 20% in the past one month and 32% since the beginning of the calendar year 2022.
Sensex, Nifty to open in red; Maruti, Future Retail, RIL, Tata Motors, Adani group shares in focus
The BSE Sensex and the NSE Nifty are set to open lower on Wednesday, mirroring weakness in global equities and negative trade at SGX Nifty.
Soft opening seen for Sensex, Nifty; Airtel, RIL, Future Retail, Sun Pharma shares in focus
The BSE Sensex and the NSE Nifty are set to start the week on a bearish note, following soft cues from Asian peers and negative trade at SGX Nifty.
Russia-Ukraine crisis, FIIs, GDP data, auto sales figures; here’s what will move market this week
From the Russia-Ukraine crisis to GDP data to ongoing state elections to sales figures of auto companies – this week is going to be action-packed for Dalal Street.
Positive opening seen for Sensex, Nifty; RIL, Sun Pharma, BPCL, Wipro, Hero MotoCorp shares in focus
The BSE Sensex and the NSE Nifty are seen opening higher, following firm cues from Asian peers and positive trends on the SGX Nifty futures.
From ₹44 to ₹292: Watch out! This textile stock surged 550% in 10 months!
This multibagger stock jumped from 52-week low of ₹44 on April 19, 2021, to ₹292.55.
Gap-down opening seen for Sensex, Nifty; Infosys, IndiGo, Federal Bank shares in focus
The BSE Sensex and the NSE Nifty are poised to open loser on Monday, following weak cues from global peers and negative trends on the SGX Nifty.
₹3 to ₹144: This penny stock turned ₹1 lakh into ₹46 lakh in one year!
Investment of ₹1 lakh in this multibagger stock at ₹3.15 apiece in February last year would have now turned into around ₹46 lakh.
Why Cipla shares tumbled 5% today?
The pharma stock has generated a 10% return in the past year but has remained flat since the beginning of the calendar year 2022.
